Live feed
Filing
SC 13G
SC 13G0001609251-17-000004·ENANTA PHARMACEUTICALS INC
Schedule 13G ownership disclosure
ENANTA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 29231M106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 883,902
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001609251-17-000004
- Form type
- SC 13G
- Filer
- ENANTA PHARMACEUTICALS INC
- CIK
- CIK 1177648
- Filed
- Feb 15, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership